UniProtKB/Swiss-Prot P04440 : Variant p.Arg125Lys
HLA class II histocompatibility antigen, DP beta 1 chain
Feedback ?
Variant information
Variant position:
125
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
125 (R125K, p.Arg125Lys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution).following page
Polymorphism:
Additional information on the polymorphism described.
Variant description:
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
125
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
258
The length of the canonical sequence.
Location on the sequence:
R VNVSPSKKGPLQHHNLLVCH
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
30 – 258 HLA class II histocompatibility antigen, DP beta 1 chain
Topological domain
30 – 225 Extracellular
Domain
124 – 212 Ig-like C1-type
Region
122 – 215 Beta-2
Beta strand
125 – 130
Literature citations
Molecular organization of the HLA-SB region of the human major histocompatibility complex and evidence for two SB beta-chain genes.
Gorski J.; Rollini P.; Long E.; Mach B.;
Proc. Natl. Acad. Sci. U.S.A. 81:3934-3938(1984)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 35-258; VARIANTS LEU-94; VAL-105; ASP-113; GLU-114; ALA-115; VAL-116; LYS-125 AND ILE-199;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.
